ELAVL1 and hepatocellular carcinoma: In our previous studies, WTAP silenced ETS1 in a HuR-dependent manner, promoting the growth of HCC [10]; ALKBH5 suppressed the malignancy of HCC via m6A-guided epigenetic modification of LYPD1 [21].